Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour

Archives of Oral Biology

Volumn 57, Issue 8, 2012, Pages 1041-1047

  Masdea, L ^a   Kulik, E M ^a   Hauser Gerspach, I ^a   Ramseier, A M ^a   Filippi, A ^a   Waltimo, T ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Bacteriocin; Deferred antagonism test; Halitosis; Solobacterium moorei; Streptococcus salivarius K12

Indexed keywords

BACTERIAL PROTEIN; BACTERIOCIN; PROBIOTIC AGENT; SALIVARICIN A;

ACTINOBACTERIA; ARTICLE; EUBACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH, DEVELOPMENT AND AGING; HALITOSIS; HUMAN; IN VITRO STUDY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; STATISTICAL MODEL; STREPTOCOCCUS;

ACTINOBACTERIA; ADMINISTRATION, ORAL; BACTERIAL PROTEINS; BACTERIOCINS; EUBACTERIUM; GRAM-POSITIVE BACTERIA; HALITOSIS; HUMANS; LINEAR MODELS; MICROBIAL SENSITIVITY TESTS; PROBIOTICS; STREPTOCOCCUS;

ATOPOBIUM PARVULUM; BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS; BULLEIDIA MOOREI; EUBACTERIUM SULCI; NEGIBACTERIA; POSIBACTERIA; STREPTOCOCCUS SALIVARIUS;

EID: 84864464587     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2012.02.011     Document Type: Article

References (35)

1. C. Scully, M. el-Maaytah, S.R. Porter, and J. Greenman Breath odor: etiopathogenesis, assessment and management Eur J Oral Sci 105 1997 287 293
2. W.J. Loesche, and C. Kazor Microbiology and treatment of halitosis Periodontol 2000 28 2002 256 279
3. C.E. Kazor, P.M. Mitchell, A.M. Lee, L.N. Stokes, W.J. Loesche, and F.E. Dewhirst Diversity of bacterial populations on the tongue dorsa of patients with halitosis and healthy patients J Clin Microbiol 41 2003 558 563
4. J.P. Burton, C.N. Chilcott, C.J. Moore, G. Speiser, and J.R. Tagg A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters J Appl Microbiol 100 2006 754 764
5. G. Reid, J. Jass, M.T. Sebulsky, and J.K. McCormick Potential uses of probiotics in clinical practice Clin Microbiol Rev 16 2003 658 672
6. L. Nase, K. Hatakka, E. Savilahti, M. Saxelin, A. Ponka, and T. Poussa Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children Caries Res 35 2001 412 420
7. A.J. Ahola, H. Yli-Knuuttila, T. Suomalainen, T. Poussa, A. Ahlström, and J.H. Meurman Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors Arch Oral Biol 47 2002 799 804
8. E.M. Comelli, B. Guggenheim, F. Stingele, and J.R. Neeser Selection of dairy bacterial strains as probiotics for oral health Eur J Oral Sci 110 2002 218 224
9. M. Montalto, M. Vastola, L. Marigo, M. Covino, R. Graziosetto, and V. Curigliano Probiotic treatment increases salivary counts of lactobacilli: a double-blind, randomized, controlled study Digestion 69 2004 53 56
10. S. Twetman, and C. Stecksen-Blicks Probiotics and oral health effects in children Int J Paediatr Dent 18 2008 3 10
11. H.P. Horz, A. Meinelt, B. Houben, and G. Conrads Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction Oral Microbiol Immunol 22 2007 126 130
12. K.F. Ross, C.W. Ronson, and J.R. Tagg Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3 Appl Environ Microbiol 59 1993 2014 2021
13. M. Upton, J.R. Tagg, P. Wescombe, and H.F. Jenkinson Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides J Bacteriol 183 2001 3931 3938
14. J.R. Tagg, and K.P. Dierksen Bacterial replacement therapy: adapting 'germ warfare' to infection prevention Trends Biotechnol 21 2003 217 223
15. V.I. Haraszthy, D. Gerber, B. Clark, P. Moses, C. Parker, and P.K. Sreenivasan Characterization and prevalence of Solobacterium moorei associated with oral halitosis J Breath Res 2 2008 017002
16. J.R. Tagg, and L.V. Bannister Fingerprinting beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors J Med Microbiol 12 1979 397 411
17. R Development Core Team R: a language and environment for statistical computing 2011 R Foundation for Statistical Computing Vienna, Austria
18. R.W. Jack, J.R. Tagg, and B. Ray Bacteriocins of Gram-positive bacteria Microbiol Rev 59 1995 171 200
19. P.D. Cotter, C. Hill, and R.P. Ross Bacteriocins: developing innate immunity for food Nat Rev Microbiol 3 2005 777 788
20. J. Cleveland, T.J. Montville, I.F. Nes, and M.L. Chikindas Bacteriocins: safe, natural antimicrobials for food preservation Int J Food Microbiol 71 2001 1 20
21. C. Chatterjee, M. Paul, L. Xie, and W.A. van der Donk Biosynthesis and mode of action of lantibiotics Chem Rev 105 2005 633 684
22. L. De Vuyst, and F. Leroy Bacteriocins from lactic acid bacteria: production, purification, and food applications J Mol Microbiol Biotechnol 13 2007 194 199
23. O. Gillor, A. Etzion, and M.A. Riley The dual role of bacteriocins as anti- and probiotics Appl Microbiol Biotechnol 81 2008 591 606
24. J.H. Meurman Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci 113 2005 188 196
25. B.J. Paster, I. Olsen, J.A. Aas, and F.E. Dewhirst The breadth of bacterial diversity in the human periodontal pocket and other oral sites Periodontol 2000 42 2006 80 87
26. J.D. Hillman, T.A. Brooks, S.M. Michalek, C.C. Harmon, J.L. Snoep, and C.C. van Der Weijden Construction and characterization of an effector strain of Streptococcus mutans for replacement therapy of dental caries Infect Immun 68 2000 543 549
27. J.D. Hillman, J. Mo, E. McDonell, D. Cvitkovitch, and C.H. Hillman Modification of an effector strain for replacement therapy of dental caries to enable clinical safety trials J Appl Microbiol 102 2007 1209 1219
28. J.R. Tagg Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius Indian J Med Res 119 Suppl. 2004 13 16
29. P.A. Wescombe, N.C. Heng, J.P. Burton, C.N. Chilcott, and J.R. Tagg Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics Future Microbiol 4 2009 819 835
30. P.A. Wescombe, M. Upton, P. Renault, R.E. Wirawan, D. Power, and J.P. Burton Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius Microbiology 157 2011 1290 1299
31. S. Guglielmetti, V. Taverniti, M. Minuzzo, S. Arioli, M. Stuknyte, and M. Karp Oral bacteria as potential probiotics for the pharyngeal mucosa Appl Environ Microbiol 76 2010 3948 3958
32. P.A. Wescombe, J.P. Burton, P.A. Cadieux, N.A. Klesse, O. Hyink, and N.C. Heng Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius Anton Van Leeuw 90 2006 269 280
33. O. Hyink, P.A. Wescombe, M. Upton, N. Ragland, J.P. Burton, and J.R. Tagg Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12 Appl Environ Microbiol 73 2007 1107 1113
34. A. Gravesen, M. Ramnath, K.B. Rechinger, N. Andersen, L. Jansch, and Y. Hechard High-level resistance to class IIa bacteriocins is associated with one general mechanism in Listeria monocytogenes Microbiology 148 2002 2361 2369
35. K. Naghmouchi, E. Kheadr, C. Lacroix, and I. Fliss Class I/Class IIa bacteriocin cross-resistance phenomenon in Listeria monocytogenes Food Microbiol 24 2007 718 727